Timberwolves, Blazers to Participate in Mayo Clinic’s Antibody Study
The Minnesota Timberwolves and Portland Trailblazers will be two of the first NBA teams to participate in the Mayo Clinic’s antibody study.
The purpose of the novel research is to study the antibodies of people who have recovered from COVID-19 in hopes of developing a vaccine. Multiple players across the NBA who have tested positive for the virus have donated their plasma toward medical research upon fully recovering.
Last month, Wolves star Karl-Anthony Towns donated $100,000 to the Mayo Clinic. Towns lost his mother to coronavirus and his father tested positive for the virus as well, but has been able to recover.
“Our team has been working around the clock for the past month to develop a test for COVID-19,” says Dr. William Morice II, chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. “We are blown away by Karl’s gesture to help us fast-track offering testing to more patients across Minnesota and the nation.”
Multiple MLB players and personnel have already participated in a similar study conducted by Stanford University.